Scientific Editor, BioPharm International

Amy Ritter, PhD

Articles

Ontario-area scientists discuss approaches to development of stem-cell therapies.

Translating Stem Cells From Laboratory to Clinic

AstraZeneca announced further downsizing in response to an expected period of declining revenues in the face of patent expirations. The company will eliminate 2300 positions in sales and general administration.

AstraZeneca Announces an Additional 2300 Layoffs

AstraZeneca announced that it will consolidate its R&D capabilities into three centers located in Cambridge, UK; Gaithersburg, MD in the US; and M?lndal, Sweden. The reorganization will result in a net loss of 1600 position, mostly in the US and the UK.

AstraZeneca to Cut 1600 Positions in R&D Reorganization

INTERPOL and 29 of the world's largest pharmaceutical companies have joined forces in an initiative to battle counterfeit drugs.

Author | Amy Ritter, PhD